Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review.

Komrokji R, Ifthikharuddin JJ, Felgar RE, Abboud CN, Wedow LA, Connaughton A, Bennett JM.

Am J Hematol. 2004 Aug;76(4):389-94. Review.

2.

Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome.

Solomon SR, Savani BN, Childs R, Montero A, Boss C, Read EJ, Leitman SF, Barrett AJ.

Biol Blood Marrow Transplant. 2005 Aug;11(8):619-26.

3.

Late diversification in the clonal composition of human cytomegalovirus-specific CD8+ T cells following allogeneic hemopoietic stem cell transplantation.

Gandhi MK, Wills MR, Okecha G, Day EK, Hicks R, Marcus RE, Sissons JG, Carmichael AJ.

Blood. 2003 Nov 1;102(9):3427-38. Epub 2003 Jul 17.

4.

The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann syndrome.

Ebihara Y, Manabe A, Tsuruta T, Ishikawa K, Hasegawa D, Ohtsuka Y, Kawasaki H, Ogami K, Wada Y, Kanda T, Tsuji K.

Int J Hematol. 2007 Dec;86(5):446-50. doi: 10.1532/IJH97.07111.

PMID:
18192114
5.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.

6.

Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.

Depil S, Deconinck E, Milpied N, Sutton L, Witz F, Jouet JP, Damaj G, Yakoub-Agha I; Société Française de Greffe de Moelle et Thérapie cellulaire.

Bone Marrow Transplant. 2004 Mar;33(5):531-4.

PMID:
14716345
8.

Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT).

Michallet AS, Nicolini F, Fürst S, Le QH, Dubois V, Hayette S, Bourgeot JP, Tremisi JP, Thomas X, Gebuhrer L, Michallet M.

Bone Marrow Transplant. 2005 Mar;35(6):601-8.

PMID:
15756285
9.

Autologous del(20q)-positive erythroid progenitor cells, re-emerging after DLI treatment of an MDS patient relapsing after allo-SCT, can provide a normal peripheral red blood cell count.

Dykes JH, Lindmark A, Lenhoff S, Winqvist I, Johansson B, Olofsson T, Olsson ML.

Bone Marrow Transplant. 2004 Mar;33(5):559-63.

PMID:
14716343
10.
11.

Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.

Donckier V, Troisi R, Toungouz M, Colle I, Van Vlierberghe H, Jacquy C, Martiat P, Stordeur P, Zhou L, Boon N, Lambermont M, Schandené L, Van Laethem JL, Noens L, Gelin M, de Hemptinne B, Goldman M.

Transpl Immunol. 2004 Sep-Oct;13(2):139-46.

PMID:
15380544
12.

Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience.

Buchholz S, Dammann E, Koenecke Ch, Stadler M, Franzke A, Blasczyk R, Bremer M, Krauter J, Hertenstein B, Ganser A, Eder M.

Ann Hematol. 2008 Jul;87(7):551-6. doi: 10.1007/s00277-008-0466-z. Epub 2008 Apr 3.

PMID:
18386010
13.

High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma.

Bloor AJ, Thomson K, Chowdhry N, Verfuerth S, Ings SJ, Chakraverty R, Linch DC, Goldstone AH, Peggs KS, Mackinnon S.

Biol Blood Marrow Transplant. 2008 Jan;14(1):50-8.

14.

Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.

Bader P, Niemeyer C, Willasch A, Kreyenberg H, Strahm B, Kremens B, Gruhn B, Dilloo D, Vormoor J, Lang P, Niethammer D, Klingebiel T, Beck JF.

Br J Haematol. 2005 Mar;128(5):649-58.

PMID:
15725087
15.

Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation.

Takami A, Okumura H, Yamazaki H, Kami M, Kim SW, Asakura H, Endo T, Nishio M, Minauchi K, Kumano K, Sugimori N, Mori S, Takemoto Y, Shimadoi S, Ozaki J, Takaue Y, Nakao S.

Int J Hematol. 2005 Dec;82(5):449-55.

PMID:
16533751
16.

Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation.

Miyazaki Y, Mori Y, Kishimoto N, Matsumoto N, Zen K, Amakawa R, Kishimoto Y, Fukuhara S.

Int J Hematol. 2003 Oct;78(3):262-5.

PMID:
14604287
17.
18.

[Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].

Ishikawa I, Miyamura K, Yamada M, Sasaki O, Harigae H, Kameoka J, Meguro K, Sasaki T.

Rinsho Ketsueki. 2005 Dec;46(12):1288-92. Japanese.

PMID:
16447801
19.

[Donor peripheral hematopoietic stem cells infusion for prophylaxis of relapse of high risk leukemia after allogeneic hematopoietic stem cell transplantation].

Liu DH, Huang XJ, Chen H, Xu LP, Liu KY, Han W, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2006 Jan;27(1):6-9. Chinese.

PMID:
16732930
20.

Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation.

Barkholt L, Danielsson R, Calissendorff B, Svensson L, Malihi R, Remberger M, Uzunel M, Thörne A, Ringdén O.

Transplantation. 2004 Sep 15;78(5):697-703.

PMID:
15371671
Items per page

Supplemental Content

Write to the Help Desk